Report Detail
Global Placental Stem Cell Therapy Market Growth (Status and Outlook) 2021-2026
- RnM4302216 |
- 06 April, 2021 |
- Global |
- 87 Pages |
- LPI(LP Information) |
- Medical Devices & Consumables
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Placental Stem Cell Therapy Market Size 2016-2026
- 2.1.2 Placental Stem Cell Therapy Market Size CAGR by Region 2020 VS 2021 VS 2026
- 2.2 Placental Stem Cell Therapy Segment by Type
- 2.2.1 Hematologic Malignancies and Disorders
- 2.2.2 Hematologic Malignancies and Disorders
- 2.2.3 Metabolic Disorders
- 2.2.4 Neurological Disorders
- 2.2.5 Others
- 2.3 Placental Stem Cell Therapy Market Size by Type
- 2.3.1 Global Placental Stem Cell Therapy Market Size CAGR by Type
- 2.3.2 Global Placental Stem Cell Therapy Market Size Market Share by Type (2016-2021)
- 2.4 Placental Stem Cell Therapy Segment by Application
- 2.4.1 Hospitals and Specialty Clinics
- 2.4.2 Clinical Research Organizations
- 2.4.3 Research Institutes and Academies
- 2.4.4 Others
- 2.5 Placental Stem Cell Therapy Market Size by Application
- 2.5.1 Global Placental Stem Cell Therapy Market Size CAGR by Application
- 2.5.2 Global Placental Stem Cell Therapy Market Size Market Share by Application (2016-2021)
3 Placental Stem Cell Therapy Market Size by Players
- 3.1 Placental Stem Cell Therapy Market Size Market Share by Players
- 3.1.1 Global Placental Stem Cell Therapy Revenue by Players (2019-2021E)
- 3.1.2 Global Placental Stem Cell Therapy Revenue Market Share by Players (2019-2021E)
- 3.2 Global Placental Stem Cell Therapy Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Placental Stem Cell Therapy by Regions
- 4.1 Placental Stem Cell Therapy Market Size by Regions (2016-2021)
- 4.2 Americas Placental Stem Cell Therapy Market Size Growth (2016-2021)
- 4.3 APAC Placental Stem Cell Therapy Market Size Growth (2016-2021)
- 4.4 Europe Placental Stem Cell Therapy Market Size Growth (2016-2021)
- 4.5 Middle East & Africa Placental Stem Cell Therapy Market Size Growth (2016-2021)
5 Americas
- 5.1 Americas Placental Stem Cell Therapy Market Size by Country (2016-2021)
- 5.2 Americas Placental Stem Cell Therapy Market Size by Type (2016-2021)
- 5.3 Americas Placental Stem Cell Therapy Market Size by Application (2016-2021)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Placental Stem Cell Therapy Market Size by Region (2016-2021)
- 6.2 APAC Placental Stem Cell Therapy Market Size by Type (2016-2021)
- 6.3 APAC Placental Stem Cell Therapy Market Size by Application (2016-2021)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Placental Stem Cell Therapy by Country (2016-2021)
- 7.2 Europe Placental Stem Cell Therapy Market Size by Type (2016-2021)
- 7.3 Europe Placental Stem Cell Therapy Market Size by Application (2016-2021)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Placental Stem Cell Therapy by Region (2016-2021)
- 8.2 Middle East & Africa Placental Stem Cell Therapy Market Size by Type (2016-2021)
- 8.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Application (2016-2021)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Placental Stem Cell Therapy Market Forecast
- 10.1 Global Placental Stem Cell Therapy Forecast by Regions (2021-2026)
- 10.1.1 Global Placental Stem Cell Therapy Forecast by Regions (2021-2026)
- 10.1.2 Americas Placental Stem Cell Therapy Forecast
- 10.1.3 APAC Placental Stem Cell Therapy Forecast
- 10.1.4 Europe Placental Stem Cell Therapy Forecast
- 10.1.5 Middle East & Africa Placental Stem Cell Therapy Forecast
- 10.2 Americas Placental Stem Cell Therapy Forecast by Countries (2021-2026)
- 10.2.1 United States Placental Stem Cell Therapy Market Forecast
- 10.2.2 Canada Placental Stem Cell Therapy Market Forecast
- 10.2.3 Mexico Placental Stem Cell Therapy Market Forecast
- 10.2.4 Brazil Placental Stem Cell Therapy Market Forecast
- 10.3 APAC Placental Stem Cell Therapy Forecast by Region (2021-2026)
- 10.3.1 China Placental Stem Cell Therapy Market Forecast
- 10.3.2 Japan Placental Stem Cell Therapy Market Forecast
- 10.3.3 Korea Placental Stem Cell Therapy Market Forecast
- 10.3.4 Southeast Asia Placental Stem Cell Therapy Market Forecast
- 10.3.5 India Placental Stem Cell Therapy Market Forecast
- 10.3.6 Australia Placental Stem Cell Therapy Market Forecast
- 10.4 Europe Placental Stem Cell Therapy Forecast by Country (2021-2026)
- 10.4.1 Germany Placental Stem Cell Therapy Market Forecast
- 10.4.2 France Placental Stem Cell Therapy Market Forecast
- 10.4.3 UK Placental Stem Cell Therapy Market Forecast
- 10.4.4 Italy Placental Stem Cell Therapy Market Forecast
- 10.4.5 Russia Placental Stem Cell Therapy Market Forecast
- 10.5 Middle East & Africa Placental Stem Cell Therapy Forecast by Region (2021-2026)
- 10.5.1 Egypt Placental Stem Cell Therapy Market Forecast
- 10.5.2 South Africa Placental Stem Cell Therapy Market Forecast
- 10.5.3 Israel Placental Stem Cell Therapy Market Forecast
- 10.5.4 Turkey Placental Stem Cell Therapy Market Forecast
- 10.5.5 GCC Countries Placental Stem Cell Therapy Market Forecast
- 10.6 Global Placental Stem Cell Therapy Forecast by Type (2021-2026)
- 10.7 Global Placental Stem Cell Therapy Forecast by Application (2021-2026)
11 Key Players Analysis
- 11.1 Lifebank Stem Cell Banking
- 11.1.1 Lifebank Stem Cell Banking Company Information
- 11.1.2 Lifebank Stem Cell Banking Placental Stem Cell Therapy Product Offered
- 11.1.3 Lifebank Stem Cell Banking Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
- 11.1.4 Lifebank Stem Cell Banking Main Business Overview
- 11.1.5 Lifebank Stem Cell Banking Latest Developments
- 11.2 Cynata
- 11.2.1 Cynata Company Information
- 11.2.2 Cynata Placental Stem Cell Therapy Product Offered
- 11.2.3 Cynata Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
- 11.2.4 Cynata Main Business Overview
- 11.2.5 Cynata Latest Developments
- 11.3 Celularity
- 11.3.1 Celularity Company Information
- 11.3.2 Celularity Placental Stem Cell Therapy Product Offered
- 11.3.3 Celularity Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
- 11.3.4 Celularity Main Business Overview
- 11.3.5 Celularity Latest Developments
- 11.4 Athersys
- 11.4.1 Athersys Company Information
- 11.4.2 Athersys Placental Stem Cell Therapy Product Offered
- 11.4.3 Athersys Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
- 11.4.4 Athersys Main Business Overview
- 11.4.5 Athersys Latest Developments
- 11.5 Americord Registry
- 11.5.1 Americord Registry Company Information
- 11.5.2 Americord Registry Placental Stem Cell Therapy Product Offered
- 11.5.3 Americord Registry Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
- 11.5.4 Americord Registry Main Business Overview
- 11.5.5 Americord Registry Latest Developments
- 11.6 ReNeuron Group
- 11.6.1 ReNeuron Group Company Information
- 11.6.2 ReNeuron Group Placental Stem Cell Therapy Product Offered
- 11.6.3 ReNeuron Group Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
- 11.6.4 ReNeuron Group Main Business Overview
- 11.6.5 ReNeuron Group Latest Developments
- 11.7 ReeLabs
- 11.7.1 ReeLabs Company Information
- 11.7.2 ReeLabs Placental Stem Cell Therapy Product Offered
- 11.7.3 ReeLabs Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
- 11.7.4 ReeLabs Main Business Overview
- 11.7.5 ReeLabs Latest Developments
- 11.8 Mesoblast
- 11.8.1 Mesoblast Company Information
- 11.8.2 Mesoblast Placental Stem Cell Therapy Product Offered
- 11.8.3 Mesoblast Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
- 11.8.4 Mesoblast Main Business Overview
- 11.8.5 Mesoblast Latest Developments
- 11.9 Pluristem Therapeutics
- 11.9.1 Pluristem Therapeutics Company Information
- 11.9.2 Pluristem Therapeutics Placental Stem Cell Therapy Product Offered
- 11.9.3 Pluristem Therapeutics Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
- 11.9.4 Pluristem Therapeutics Main Business Overview
- 11.9.5 Pluristem Therapeutics Latest Developments
12 Research Findings and Conclusion
According to this latest study, the 2021 growth of Placental Stem Cell Therapy will have significant change from previous year. By the most conservative estimates of global Placental Stem Cell Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Placental Stem Cell Therapy market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Placental Stem Cell Therapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Hematologic Malignancies and Disorders
Congenital Immunodeficiency Disorders
Metabolic Disorders
Neurological Disorders
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals and Specialty Clinics
Clinical Research Organizations
Research Institutes and Academies
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Lifebank Stem Cell Banking
Cynata
Celularity
Athersys
Americord Registry
ReNeuron Group
ReeLabs
Mesoblast
Pluristem Therapeutics
Summary:
Get latest Market Research Reports on Placental Stem Cell Therapy. Industry analysis & Market Report on Placental Stem Cell Therapy is a syndicated market report, published as Global Placental Stem Cell Therapy Market Growth (Status and Outlook) 2021-2026. It is complete Research Study and Industry Analysis of Placental Stem Cell Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
